San Diego, Calif. – May 9, 2013 – Cooley LLP announced that it advised Insys Therapeutics on its initial public offering. Insys Therapeutics, now trading on the NASDAQ Stock Market under the symbol "INSY," is an Arizona-based commercial-stage specialty pharmaceutical company. Insys develops and commercializes innovative supportive care products, with a focus on utilizing its proprietary formulation technologies to address the clinical shortcomings of existing commercial pharmaceutical products.
The Cooley corporate securities team advising Insys Therapeutics included partners Charlie Kim, Matthew Browne and Sean Clayton, and associates Asa Henin, Kevin Henderson, Brandon Batt and Terren O'Connor. Regulatory expertise was provided by partners Natasha Leskovsek and Drew Gantt and associate David Sclar. Partner Amy Wood and associate Megan Arthur provided compensation and benefits expertise and partner Susan Cooper Philpot provided tax expertise.
About Cooley LLP
Cooley's 700 attorneys have an entrepreneurial spirit and deep, substantive experience, and are committed to solving clients' most challenging legal matters. From small clients with big ideas to international clients with diverse legal needs, Cooley has the breadth of legal resources to enable clients of all shapes and sizes to seize opportunities in today's global marketplace. We represent clients across a broad array of dynamic industry sectors, including the financial sector, law firms, media, technology, life sciences, health care, venture capital, clean energy, real estate and retail.
Based on the data in American Lawyer's 2012 Corporate Scorecard, Cooley served as issuer counsel on 40 total US equity offerings, ranking as the most active law firm advising issuers in the country. Cooley was also the third most active law firm advising underwriters on US IPOs.
Cooley has full-service offices in eleven major business and technology centers: Boston, MA; Broomfield, CO; Los Angeles, CA; New York, NY; Palo Alto, CA; Reston, VA; San Diego, CA; San Francisco, CA; Seattle, WA; Washington, DC; and Shanghai, China.